Quantamental Technologies LLC Vertex Pharmaceuticals Inc Transaction History

Quantamental Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $757,956 - $956,812	-4,282 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $410,122 - $458,960	2,261 Added 111.88%	4,282 $777,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $378,917 - $446,843	2,021 New	2,021 $407,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $863,024 - $1.15 Million	-4,169 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $105,327 - $124,877	412 Added 10.97%	4,169 $1.13 Million

Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $170,688 - $223,920	757 Added 25.23%	3,757 $1.09 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $359,186 - $445,562	1,798 Added 149.58%	3,000 $714,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $62,849 - $84,414	377 Added 45.7%	1,202 $263,000
Q3 2019 Nov 08, 2019	SELL	$166.23 - $187.09 $849,601 - $956,216	-5,111 Reduced 86.1%	825 $140,000
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $911,939 - $1.05 Million	5,540 Added 1398.99%	5,936 $1.09 Million
Q1 2019 Apr 29, 2019	BUY	$163.73 - $194.7 $24,723 - $29,399	151 Added 61.63%	396 $73,000
Q4 2018 Jan 28, 2019	BUY	$151.91 - $192.21 $37,217 - $47,091	245 New	245 $41,000

1,624

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.